Leaflet NAABAK 49mg / ml ophthalmic drops solution

Product code:
W43641001
Quantity:
1
Indicated for:
allergic conjunctivitis
Route of administration:
ophthalmic
Substance:
n-acetyl aspartyl glutamic acid (antiallergic agent)
ATC
S01GX03 — Sensory organs | Decongestants and antiallergics | Other antiallergics
N-Acetylaspartylglutamic acid (NAAG) is a dipeptide composed of N-acetylaspartic acid and glutamic acid, naturally present in the central nervous system. It is considered a neurotransmitter or neuromodulator involved in regulating neuronal functions, playing an important role in cognitive processes, memory, and neuroprotection.

NAAG acts by binding to metabotropic glutamate receptors (mGluR3), where it can reduce the excessive release of glutamate, an excitatory neurotransmitter that, in high amounts, can cause neurotoxicity. It also has potential neuroprotective and anti-inflammatory properties and is being investigated for its use in conditions such as multiple sclerosis, Alzheimer’s disease, neuropathic pain, and other neurological disorders.

Although it is a promising substance, its therapeutic use is still under research, and its safety and efficacy are not yet fully established. Any use should be supervised by a specialist.

General data about NAABAK 49mg / ml

Substance:
n-acetyl aspartyl glutamic acid
Date of latest medicines list:
01-07-2013
Product code:
W43641001
Concentration:
49mg / ml
Pharmaceutical form:
ophthalmic drops solution
Packing volume:
10 ml
Product type:
Generic medicine
Prescription status:
OTC — Over the Counter = medicine that does not require a medical prescription.

Marketing authorisation

Manufacturer:
THISSEN LABORATOIRES SA - BELGIA
Holder:
LABORATOIRES THEA - FRANTA
Number:
12887/2019/01
Shelf life:
2 years